(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

THE DUCHENNE REGISTRY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

THE DUCHENNE REGISTRY

ST13

US500000088093836

Class

42, 44

Filing

88093836

Registration

5893388

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

02/12/2026

Trademark type

Word

Nice classes

42, 44

Filing date

08/27/2018

Registration date

10/22/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/11/2026

Last transaction

02/12/2026

Responsible office

United States Patent and Trademark Office

Status code

701

Official register

Supplemental Register

First use anywhere

05/02/2018

First use in commerce

05/02/2018

Drawing code

4

Owner type

03

Owner location

WASHINGTON, DC

Examiner

HA, PAULINE T.

Current location

Historical data usage

Holders and representatives

Holders

THE PARENT PROJECT FOR MUSCULAR DYSTROPHY RESEARCH, INC.
THE PARENT PROJECT FOR MUSCULAR DYSTROPHY RESEARCH, INC.

Representatives

Tracey A. Puthoff TAFT STETTINIUS & HOLLISTER LLP

Technical classification

Nice Classes

Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Providing a website that features medical and scientific research information in the field of clinical trials and genetic testing; providing on-line resource guides in the nature of providing a website featuring information in the fields of medical and scientific research studies and clinical trials for individuals concerned with muscular dystrophy

Class 44

Providing on-line resource guides in the nature of providing a website featuring information in the fields of disease management programsmedical diagnosis and treatment for individuals concerned with muscular dystrophy

Publications

History of USPTO decisions and trademark events.

28 publications found

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

02/11/2026

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

02/11/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/08/2026

ES8R

TEAS SECTION 8 RECEIVED

09/23/2025

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

10/22/2024

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

08/23/2023

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

10/22/2019

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

09/19/2019

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

09/13/2019

XAEC

EXAMINER'S AMENDMENT ENTERED

09/12/2019

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

09/12/2019

GNEA

EXAMINERS AMENDMENT E-MAILED

09/12/2019

CNEA

EXAMINERS AMENDMENT -WRITTEN

09/12/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/24/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/24/2019

ALIE

ASSIGNED TO LIE

08/22/2019

NREV

NOTICE OF REVIVAL - E-MAILED

08/15/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/14/2019

PETG

PETITION TO REVIVE-GRANTED

08/14/2019

PROA

TEAS PETITION TO REVIVE RECEIVED

08/14/2019

MAB2

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

07/10/2019

ABN2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

07/10/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/12/2018

GNRT

NON-FINAL ACTION E-MAILED

12/12/2018

CNRT

NON-FINAL ACTION WRITTEN

12/12/2018

DOCK

ASSIGNED TO EXAMINER

12/11/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/06/2018

NWAP

NEW APPLICATION ENTERED

08/30/2018

Continuous trademark protection

Get notified about every new filing that threatens THE DUCHENNE REGISTRY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.